Biotech Travere Therapeutics and CSL Vifor Announce EMA has Accepted for Review the Conditional Marketing Authorization Application for Sparsentan for the Treatment of IgA Nephropathy August 23, 2022
Biotech Arcutis Announces Arcutis Cares(TM) Patient Assistance Program (PAP) For Financially Qualified Uninsured and Underinsured Patients August 23, 2022
Biotech Veru Granted Expedited Provisional Registration Regulatory Pathway for Sabizabulin Treatment in Hospitalized COVID-19 Patients by Australia’s Therapeutic Goods Administration August 23, 2022
Biotech REGENXBIO Announces Presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium August 23, 2022
Biotech Arcutis Completes Enrollment in INTEGUMENT-2 Pivotal Phase 3 Trial of Ro?umilast Cream in Atopic Dermatitis August 23, 2022
Biotech Veru Announces Appointment of Jason Davies to Lead EMEA, LATAM and APAC Infectious Disease Franchise for Veru International Focused on Hospitalized COVID-19 Patients August 22, 2022
Biotech FDA Accepts Krystal Biotech’s Biologics License Application for Dystrophic Epidermolysis Bullosa August 19, 2022
Biotech SpringWorks Therapeutics Announces Late-Breaking Oral Presentation of Phase 3 DeFi Data at the European Society for Medical Oncology (ESMO) Congress 2022 August 19, 2022
Search
Biotech
August 24, 2022
August 23, 2022
August 23, 2022
August 23, 2022
August 23, 2022
August 23, 2022
August 22, 2022
August 19, 2022
August 19, 2022
August 19, 2022
